Status:
RECRUITING
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
Lead Sponsor:
Fudan University
Conditions:
Solid Pseudopapillary Neoplasm of the Pancreas
Eligibility:
All Genders
Brief Summary
To establish and maintain a reliable multicenter real-world database for pancreatic SPN, providing high-quality data and evidence-based support for clinical/translational research.
Detailed Description
Pancreatic solid pseudopapillary neoplasm (SPN) is a low-grade malignant tumor, accounting for 0.2%-2.7% of pancreatic tumors, with unique histological and biological characteristics. Its pathological...
Eligibility Criteria
Inclusion
- No restrictions on age, gender, or performance status;
- Pathologically/cytologically confirmed SPN;
- Compliance with follow-up requirements;
Exclusion
- Non-neoplastic pancreatic lesions;
- Non-pancreatic primary tumors;
- Non-compliance with follow-up;
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2041
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT07183280
Start Date
September 1 2025
End Date
December 30 2041
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Cancer Center
Shanghai, Special Administrative Region, China, 200032